These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 3506626)

  • 1. The effect of chronic prazosin therapy on the response of the renin-angiotensin system in patients with essential hypertension.
    Webb DJ; Fulton JD; Leckie BJ; Malatino LS; McAreavey D; Morton JJ; Murray GD; Robertson JI
    J Hum Hypertens; 1987 Dec; 1(3):195-200. PubMed ID: 3506626
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of losartan on the renin-angiotensin-aldosterone axis in essential hypertension.
    Bauer IH; Reams GP; Wu Z; Lau-Sieckman A
    J Hum Hypertens; 1995 Apr; 9(4):237-43. PubMed ID: 7595905
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative effects of pinacidil and prazosin on blood pressure, weight, plasma volume, the renin-angiotensin-aldosterone system, and the renal kallikrein-kinin system in patients with essential hypertension.
    Solomon RJ; Weinberg MS
    J Clin Hypertens; 1987 Dec; 3(4):589-95. PubMed ID: 3330989
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of acute and chronic losartan therapy on active and inactive renin and active renin glycoforms.
    Opsahl JA; Goldberg MR; Katz SA
    Am J Hypertens; 1995 Nov; 8(11):1090-8. PubMed ID: 8554732
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute effects of a pseudo-tetrapeptide as renin inhibitor on blood pressure and renin-angiotensin system of sodium-repleted and sodium-depleted hypertensive patients.
    Denolle T; Luo P; Guyene TT; Cazaubon C; Sissmann J; Corvol P; Ménard J
    Arzneimittelforschung; 1993 Feb; 43(2A):255-9. PubMed ID: 8498973
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of plasma angiotensin I converting enzyme in regulation of renin-angiotensin system activity in patients with essential hypertension.
    Ishida H; Shimamoto K; Ando T; Nishitani T; Hosoda S; Yokoyama T; Fukuyama S; Mori Y; Nakagawa H; Ogata H
    J Clin Hypertens; 1987 Dec; 3(4):681-4. PubMed ID: 2839630
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Blood pressure effects of acute intravenous renin or oral angiotensin converting enzyme inhibition in essential hypertension.
    Azizi M; Guyene TT; Chatellier G; Ménard J
    J Hypertens; 1994 Apr; 12(4):419-27. PubMed ID: 8064166
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Blood pressure dependency on vasopressin and angiotensin II in prazosin-treated conscious normotensive rats.
    Waeber B; Nussberger J; Brunner HR
    J Pharmacol Exp Ther; 1983 May; 225(2):442-6. PubMed ID: 6341543
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The state and responsiveness of the renin-angiotensin-aldosterone system in patients with type II diabetes mellitus.
    Price DA; De'Oliveira JM; Fisher ND; Williams GH; Hollenberg NK
    Am J Hypertens; 1999 Apr; 12(4 Pt 1):348-55. PubMed ID: 10232494
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effect of inhibition of converting enzyme by captopril on arterial pressure, renin and aldosterone in essential hypertension].
    Posadas C; Sánchez G; Boyer JL; Delmar M; Serrano PA
    Arch Inst Cardiol Mex; 1982; 52(4):295-300. PubMed ID: 6291470
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Acute effect of nifedipine on arterial pressure and the renin-angiotensin system in healthy subjects and hypertensives].
    Ribstein J; de Treglode D; Mimran A
    Arch Mal Coeur Vaiss; 1985 Nov; 78 Spec No():29-32. PubMed ID: 3937502
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of prazosin in the control of blood pressure in hypertensive dialysis patients.
    Harter HR; Delmez JA
    J Cardiovasc Pharmacol; 1979; 1(6 Suppl):S43-55. PubMed ID: 94639
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antihypertensive therapy with MK 421: angiotensin II--renin relationships to evaluate efficacy of converting enzyme blockade.
    Biollaz J; Brunner HR; Gavras I; Waeber B; Gavras H
    J Cardiovasc Pharmacol; 1982; 4(6):966-72. PubMed ID: 6185790
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The effect of long-term treatment of arterial hypertension with Ca antagonists on the renin-angiotensin-aldosterone system in diabetics. Hyporeninemic hypoaldosteronism].
    Hrnciar J; Jakubíková K; Hrnciarová M; Kreze A; Chamulová M
    Vnitr Lek; 1995 Oct; 41(10):661-6. PubMed ID: 8578695
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Captopril in primary hypertension. Effects related to the renin-angiotensin-aldosterone and kallikrein-kinin systems.
    Ohman KP; Karlberg BE; Nilsson OR; Wettre S
    Acta Med Scand Suppl; 1981; 646():98-105. PubMed ID: 7018190
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of severe essential hypertension with labetalol: effect on active and inactive renin.
    Hauger-Klevene JH
    Pharmatherapeutica; 1981; 3(1):46-54. PubMed ID: 7033992
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Relationship of the renin-angiotensin-aldosterone system with auricular natriuretic factor in its response to the action of thiazide diuretics and to nifedipine, a sustained-release calcium antagonist].
    Ocón J; Mora-Macià J; Castellet R; del Río G
    Med Clin (Barc); 1994 Jan; 102(2):41-5. PubMed ID: 8133694
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of oral prazosin on blood pressure and plasma concentrations of renin and angiotensin II in man.
    McAreavey D; Cumming AM; Sood VP; Leckie BJ; Morton JJ; Murray GD; Robertson JI
    Clin Sci (Lond); 1981 Dec; 61 Suppl 7():457s-460s. PubMed ID: 7032827
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The relative roles of sodium and renin in the hypertension of renal disease. An assessment based on the response to frusemide and propranolol.
    Wilkinson R; Sellars L; Pickering M; Robson V; Kerr DN
    Clin Nephrol; 1981 Dec; 16(6):307-13. PubMed ID: 7032775
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of renin-angiotensin system inhibition on end-organ protection: can we do better?
    Weir MR
    Clin Ther; 2007 Sep; 29(9):1803-24. PubMed ID: 18035185
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.